Qidu Pharma’s intelligent production project for oral preparations with an annual capacity of 10 billion tablets/granules passed the GMP on-site inspection.
Netizen “Free as the Wind” wrote: “Chasing dreams across mountains and seas, we don’t feel the distance; though the road ahead stretches long, we stride ahead boldly. Let us summon the courage of a galloping steed, unleash the vitality of charging horses, and keep motivated like a horse rushing forward. Together, let’s fight for our dreams and work hard for our happiness, turning a grand vision into a beautiful reality. When each of our ‘small families’ is brimming with warmth and energy, the big family of Qidu Pharma will thrive and grow more prosperous with every passing day.”
Recommended reading
-
January 20, 2025Top Ten Events of Qidu Pharmaceutical Group in 2025 Announced
-
September 19, 2026Ujoin Medical Technology’s COP/COC Prefilled Syringe Production and Assembly Line Officially Put into Operation
-
September 19, 2026Qidu Pharmaceutical 2026: Summer Daycare and Scholarship/Bursary Programs – Care Underway
-
September 07, 2026Qidu Pharmaceutical’s Ruihuanjia® – Hemofiltration Replacement Fluid of Sodium Citrate Receives NMPA Approval for Marketing
-
September 07, 2026Qidu Pharmaceutical’s Fat Emulsion Injection (C14-24) Passes Generic Drug Consistency Evaluation
-
September 07, 2026Qidu Pharmaceutical’s Yiruiqing® - Rosuvastatin Calcium and Ezetimibe Tablets (I) Approved for Marketing
-
September 07, 2026Qidu Pharmaceutical’s First Lipid Emulsion Triple-Chamber Bag Product Laifengneng® Approved for Marketing